Carolyn Y. Johnson – Page 2

Elizabeth Holmes, founder and CEO of Theranos, speaks at the Fortune Global Forum in San Francisco, Monday, Nov. 2, 2015.

Walgreens gives up on embattled Silicon Valley startup Theranos

June 10, 2018 at 11:49 a.m.

In the latest episode of what has become one of the most gripping Silicon Valley sagas in recent memory, Walgreens officially announced Sunday night that it has terminated its partnership...

Scientists have determined how to prevent half of all cancer deaths

June 10, 2018 at 2:36 p.m.

Imagine a powerful new treatment that could cut all cancer deaths by more than half. In the age of $10,000-a-month cancer drugs that often extend life by the thinnest margins...

UnitedHealth Group, the nation's largest health insurer, said April 19, 2016, that in 2017 it will exit most of the 34 states where it offers plans on the Affordable Care Act insurance exchanges.

UnitedHealth Group to exit Affordable Care exchanges in all but a ‘handful’ of states

June 11, 2018 at 3:01 a.m.

UnitedHealth Group, the nation's largest health insurer, said today that in 2017 it will exit most of the 34 states where it offers plans on the Affordable Care Act insurance...

Theranos Chief Executive Elizabeth Holmes speaks at a Wall Street Journal technology conference in Laguna Beach, Calif., on Oct. 21, 2015.

Study raises questions about accuracy of some Theranos blood tests

June 8, 2018 at 11:38 p.m.

The proprietary technology behind the embattled blood-testing startup Theranos was substantially more likely to flag results as abnormally high or low compared with other companies, according to a new study....

Drugmaker under fire for taxpayer-funded cancer drug that costs $129,269 a year

June 1, 2019 at 5:09 a.m.

Two nonprofit groups have petitioned the federal government to take actions to increase the competition for a cancer drug, developed by a Japanese company whose U.S. affiliate is in Northbrook,...

The lingering health effects of the Civil War

August 21, 2019 at 6:06 p.m.

A map of deaths from heart disease reveals the American South ablaze in red; of the 10 states with the highest rate of death from heart disease among white people...

How an $84,000 drug got its price: ‘Let’s hold our position … whatever the headlines’

June 16, 2018 at 10:37 a.m.

Gilead Sciences executives were acutely aware in 2013 that their plan to charge an exorbitantly high price for a powerful new hepatitis C drug would spark public outrage, but they...

All Stories